Klotho Neurosciences (Nasdaq: KLTO) is a biopharmaceutical company committed to the development of disease-modifying therapies for age-related cognitive and neurodegenerative disorders.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Omaha, Ne 68144, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.klothoneuro.com
- Keywords
- gene therapy, recombinant Klotho, biosimilar biogenerics, essential medicines, needle-free drug delivery systems, melanocortin receptor analogs, contract manufacturing.
- HQ
- Omaha, NE
Klotho Neurosciences (Nasdaq: Klto) Questions
Klotho Neurosciences (Nasdaq: Klto)'s website is https://www.klothoneuro.com
Klotho Neurosciences (Nasdaq: Klto)'s LinkedIn profile is https://www.linkedin.com/company/klothoneurosciences
Klotho Neurosciences (Nasdaq: Klto) has
4 employees.
View email and phone details for 4
employees at Klotho Neurosciences (Nasdaq: Klto).
Klotho Neurosciences (Nasdaq: Klto)'s industry is
Biotechnology Research
Klotho Neurosciences (Nasdaq: Klto)'s top competitors are
Amarna Therapeutics,
Caris Life Sciences,
Mosanna Therapeutics,
Odyssey Therapeutics,
Northx Biologics,
Actio Biosciences, Inc.,
Splicebio,
Klotho Therapeutics, Inc.,
Urogen Pharma,
Metsera.
Klotho Neurosciences (Nasdaq: Klto)'s categories are Biotechnology Research
Klotho Neurosciences (Nasdaq: Klto)'s founding year is 2019
